What is the current valuation of the France Biopsy Devices Market?

As of 2024, the market valuation was 141.62 USD Million. Read More

What is the projected market size for the France Biopsy Devices Market by 2035?

The market is expected to reach a valuation of 261.17 USD Million by 2035. Read More

What is the expected CAGR for the France Biopsy Devices Market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 5.72%. Read More

Which segments are included in the France Biopsy Devices Market by application?

The market segments by application include Surgical Biopsy, Needle Biopsy, Endoscopic Biopsy, and Core Biopsy. Read More

What are the projected values for Needle Biopsy in the France Biopsy Devices Market?

The projected values for Needle Biopsy range from 40.0 to 75.0 USD Million. Read More

Who are the key players in the France Biopsy Devices Market?

Key players include Medtronic, Boston Scientific, Becton Dickinson, Hologic, Siemens Healthineers, Fujifilm, Cook Medical, Stryker, and Abbott Laboratories. Read More

What are the projected values for Biopsy Needles in the market?

The projected values for Biopsy Needles range from 40.0 to 75.0 USD Million. Read More

Which end users are significant in the France Biopsy Devices Market?

Significant end users include Hospitals, Diagnostic Laboratories, Outpatient Clinics, and Research Institutions. Read More

What is the projected value for Ultrasound-Guided Biopsy devices?

The projected value for Ultrasound-Guided Biopsy devices ranges from 40.0 to 75.0 USD Million. Read More

What device types are included in the France Biopsy Devices Market?

Device types include Biopsy Needles, Biopsy Forceps, Vacuum-Assisted Biopsy Devices, and Surgical Biopsy Devices. Read More

France Biopsy Devices Market

France Biopsy Devices Market Research Report: By Product Type (Biopsy Guns, Biopsy Guidance System, Biopsy Needles, Biopsy Forceps, Localization Wires, Others), By Application (Breast Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Gynecological Biopsy, Others), By Guidance (Ultrasound-Guided Biopsy, Stereotactic Guided Biopsy, MRI-Guided Biopsy, CT Guided Biopsy, Others) andBy End User (Hospitals & Clinics, Diagnostic & Imaging Centers, Academic & Research Institutes, Others)- Forecast to 2035

Forecast Period

2025 - 2035

CAGR

5.72%

2018 Market Size

$ 118.8 Million

2035 Market Size

$ 261.17 Million

Healthcare ● Updated August 2026 Report ID: MRFR/HC/54676-HCR | Pages: 200 | Author: Satyendra Maurya

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 France Biopsy Devices Market, BY Application (USD Million) | |
  1. 4.1.1 Surgical Biopsy | |
  2. 4.1.2 Needle Biopsy | |
  3. 4.1.3 Endoscopic Biopsy | |
  4. 4.1.4 Core Biopsy |
2. 4.2 France Biopsy Devices Market, BY Device Type (USD Million) | |
  1. 4.2.1 Biopsy Needles | |
  2. 4.2.2 Biopsy Forceps | |
  3. 4.2.3 Vacuum-Assisted Biopsy Devices | |
  4. 4.2.4 Surgical Biopsy Devices |
3. 4.3 France Biopsy Devices Market, BY End User (USD Million) | |
  1. 4.3.1 Hospitals | |
  2. 4.3.2 Diagnostic Laboratories | |
  3. 4.3.3 Outpatient Clinics | |
  4. 4.3.4 Research Institutions |
4. 4.4 France Biopsy Devices Market, BY Technology (USD Million) | |
  1. 4.4.1 Ultrasound-Guided Biopsy | |
  2. 4.4.2 CT-Guided Biopsy | |
  3. 4.4.3 MRI-Guided Biopsy | |
  4. 4.4.4 Fluoroscopy-Guided Biopsy 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the France Biopsy Devices Market | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the France Biopsy Devices Market | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Medtronic (FR) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Boston Scientific (FR) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Becton Dickinson (FR) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Hologic (FR) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Siemens Healthineers (FR) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Fujifilm (FR) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Cook Medical (FR) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Stryker (FR) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Abbott Laboratories (FR) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 FRANCE MARKET ANALYSIS BY APPLICATION |
6. 6.3 FRANCE MARKET ANALYSIS BY DEVICE TYPE |
7. 6.4 FRANCE MARKET ANALYSIS BY END USER |
8. 6.5 FRANCE MARKET ANALYSIS BY TECHNOLOGY |
9. 6.6 KEY BUYING CRITERIA OF FRANCE BIOPSY DEVICES MARKET |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF FRANCE BIOPSY DEVICES MARKET |
12. 6.9 DRIVERS IMPACT ANALYSIS: FRANCE BIOPSY DEVICES MARKET |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: FRANCE BIOPSY DEVICES MARKET |
14. 6.11 SUPPLY / VALUE CHAIN: FRANCE BIOPSY DEVICES MARKET |
15. 6.12 FRANCE BIOPSY DEVICES MARKET, BY APPLICATION, 2024 (% SHARE) |
16. 6.13 FRANCE BIOPSY DEVICES MARKET, BY APPLICATION, 2024 TO 2035 (USD Million) |
17. 6.14 FRANCE BIOPSY DEVICES MARKET, BY DEVICE TYPE, 2024 (% SHARE) |
18. 6.15 FRANCE BIOPSY DEVICES MARKET, BY DEVICE TYPE, 2024 TO 2035 (USD Million) |
19. 6.16 FRANCE BIOPSY DEVICES MARKET, BY END USER, 2024 (% SHARE) |
20. 6.17 FRANCE BIOPSY DEVICES MARKET, BY END USER, 2024 TO 2035 (USD Million) |
21. 6.18 FRANCE BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024 (% SHARE) |
22. 6.19 FRANCE BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million) | |
  2. 7.2.2 BY DEVICE TYPE, 2026-2035 (USD Million) | |
  3. 7.2.3 BY END USER, 2026-2035 (USD Million) | |
  4. 7.2.4 BY TECHNOLOGY, 2026-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

France Biopsy Devices Market Segmentation

France Biopsy Devices Market By Application (USD Million, 2022-2035)

Surgical Biopsy
Needle Biopsy
Endoscopic Biopsy
Core Biopsy

France Biopsy Devices Market By Device Type (USD Million, 2022-2035)

Biopsy Needles
Biopsy Forceps
Vacuum-Assisted Biopsy Devices
Surgical Biopsy Devices

France Biopsy Devices Market By End User (USD Million, 2022-2035)

Hospitals
Diagnostic Laboratories
Outpatient Clinics
Research Institutions

France Biopsy Devices Market By France Biopsy Devices Market (USD Million, 2022-2035)

Ultrasound-Guided Biopsy
CT-Guided Biopsy
MRI-Guided Biopsy
Fluoroscopy-Guided Biopsy

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”